Consultations
Search open and closed consultations on the way we regulate medicines, medical devices and biologicals.
- You can also find, read and respond to recent consultations, submissions and decisions at the TGA Consultation hub.
- Find more scheduling consultations on the Poisons Standard in our Interim decisions.
- Archived consultations and reviews can be viewed on the National Library of Australia Trove site.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Scheduling (national classification system) (80)
- Legislation (13)
- Committees and advisory bodies (12)
- Manufacturing (7)
- Labelling and packaging (6)
- Safety monitoring and information (5)
- Advertising (3)
- Fees and payments (3)
- Import and export (3)
- Sunscreens (3)
- Medicinal cannabis hub (2)
- Shortages and supply disruptions (2)
- Clinical trials (1)
- Compliance and enforcement (1)
- Unique Device Identification (UDI) hub (1)
- Vaping hub (1)
Use the filters or search function to help find relevant consultations.
Search
260 result(s) found, displaying 1 to 25
-
ConsultationWe are seeking feedback on the current usage of paper information included with injectable medicines.
-
ConsultationWe are seeking industry feedback on proposed amendments to strengthen the legal framework governing TMFs for blood and blood components, and PMFs for Type II plasma-derived products.
-
ConsultationThe Therapeutic Goods Administration (TGA) is seeking feedback on potential changes to the Therapeutic Goods Regulations 1990 applying to manufacturing of certain bacteriophage therapy products (BTPs) in Australia.
-
ConsultationHave your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Medicines Scheduling (ACMS), Advisory Committee on Chemicals Scheduling (ACCS), and the joint meeting of the ACMS and ACCS.
-
-
ConsultationWe are seeking stakeholder input on their experiences, observations and knowledge of the use of unapproved medicinal cannabis products to inform our considerations for future regulatory reform.
-
ConsultationIn accordance with regulation 42ZCZK of the Therapeutic Goods Regulations 1990, the Secretary invites public submissions on scheduling proposals referred to the June 2025 meetings of the Advisory Committees on Medicines and Chemicals Scheduling.
-
ConsultationWe are seeking feedback on whether we should adopt 3 international scientific guidelines.
-
ConsultationHave your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Medicines Scheduling (ACMS)
-
ConsultationWe are seeking stakeholders’ feedback on proposed changes to the IVD medical device classifications and definitions.
-
ConsultationHave your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the
Advisory Committee on Medicines Scheduling (ACMS), or a joint meeting of the ACMS and Advisory Committee on Chemicals Scheduling (ACCS) -
ConsultationHave your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Chemicals Scheduling (ACCS) and joint meeting of the Advisory Committee on Medicines Scheduling (ACMS) and ACCS.
-
ConsultationWe are seeking feedback on two new guidance documents developed as part of the proposed new risk-based application audit framework.
-
ConsultationWe are seeking feedback on whether 19 international scientific guidelines should be adopted.
-
ConsultationWe are seeking feedback on proposed improvements to TGA’s regulatory framework for medicine shortages and discontinuations in Australia.
-
ConsultationHave your say on the proposed changes to the Australian Essential Principles for Safety and Performance of medical devices (Essential Principles). Closing date has been extended from 16 October to 13 November 2024.
-
ConsultationThe TGA is seeking feedback on proposed changes to the regulation of assistive technologies.
-
ConsultationHave your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Medicines Scheduling (ACMS), meeting of the Advisory Committee on Chemicals Scheduling (ACCS), or a joint meeting of these two committees.
-
ConsultationThis consultation paper seeks feedback on proposals identified for mitigating risks and leveraging opportunities associated with the use of AI models.
-
ConsultationThis consultation is for interim decisions made in relation to substances that were discussed at the JUNE 2024 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationWe are seeking feedback on draft guidance documentation 'Regulatory changes for medical devices containing medicinal substances or materials of animal, microbial, or recombinant origin - guidance on the new regulatory requirements and transition arrangements'.
-
ConsultationWe are seeking feedback on the proposed temporary labelling exemptions for paracetamol.
-
ConsultationThe TGA sought feedback from interested parties on proposed changes to the requirements of ingredients used in listed (low-risk) medicines.
-
ConsultationThe TGA is seeking feedback from interested parties on the proposed changes to replace the sunsetting TGO 70C with a new instrument
-
ConsultationHave your say on the need for additional clarity and transparency on the regulatory category of some boundary and combination products.